Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03531853 · ClinicalTrials.gov registry record · NA
OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03531853 is a NA study that has completed, run by Duke University. The registered enrollment target is 14 participants.
The verdict
NCT03531853, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and demonstrate new technologies that will enable a non-contact, compact eye imaging system based on OCT to assist an early responder in acute care settings (like an emergency room) to help assess eye trauma and inflammation (swelling inside the eye).
Interventions
- DEVICE hand-held swept source optical coherence tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-11-14 |
| Est. Completion | 2021-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03531853
The ClinicalTrials.gov registry entry for NCT03531853 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hand-held swept source optical coherence tomography is the first listed.
NCT03531853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03531853 about?
NCT03531853 is a clinical study titled "OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers". The purpose of this study is to develop and demonstrate new technologies that will enable a non-contact, compact eye imaging system based on OCT to assist an early responder in acute care settings (like an emergency room) to help assess eye trauma and inflammation (swelling inside the eye).
What is the current status of trial NCT03531853?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-11-14. Estimated completion is 2021-03-10.
What interventions are being tested in trial NCT03531853?
The interventions under investigation include: hand-held swept source optical coherence tomography (DEVICE).
Who is sponsoring clinical trial NCT03531853?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.